Natacha Herssens

Medicine & Life Sciences

1. Malaria 100%
2. HIV 82%
3. Pre-Exposure Prophylaxis 80%
4. Burkina Faso 80%
5. HIV-1 74%
6. Hematology 73%
7. Mouthwashes 71%
8. HIV-2 70%
9. Rifampin 57%
10. Sexual and Gender Minorities 56%
11. Bacteremia 55%
12. Sexually Transmitted Diseases 53%
13. Cross-Over Studies 49%
14. Tuberculosis 45%
15. HIV Infections 43%
16. Placebos 37%
17. Safety 35%
18. Procalcitonin 35%
19. Infection 32%
20. Belgium 31%
21. C-Reactive Protein 30%
22. Tropical Medicine 24%
23. Fever 22%
24. Microscopy 21%
25. Sensitivity and Specificity 20%
26. Therapeutics 19%
27. RNA 18%
28. Pyrazinamide 18%
29. Ethambutol 17%
30. Mentha 16%
31. Bangladesh 16%
32. Isoniazid 15%
33. Drug-Related Side Effects and Adverse Reactions 12%
34. European Union 12%
35. Immunoassay 10%
36. DNA 10%
37. Incidence 10%
38. Recurrence 9%
39. Ludwig's Angina 9%
40. Randomized Controlled Trials 9%
41. Routine Diagnostic Tests 9%
42. Acquired Immunodeficiency Syndrome 9%
43. Disease Progression 8%
44. insulin receptor-related receptor 8%
45. Anti-Bacterial Agents 8%
46. Multiplex Polymerase Chain Reaction 7%
47. Western Blotting 7%
48. Equivalence Trials 7%
49. Blood Cell Count 7%